Steve Schonfeld’s Century Therapeutics IPSC Stock Holding History

Steve Schonfeld’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.8K	Buy	+21,532	New	+$49.2K	﹤0.01%	2377
2024 Q2	–	Sell	-93,085	Closed	-$389K	–	2348
2024 Q1	$389K	Buy	+93,085	New	+$394K	﹤0.01%	1563
2022 Q1	–	Sell	-12,300	Closed	-$195K	–	2740
2021 Q4	$195K	Sell	12,300 -1,300	-10%	-$24.4K	﹤0.01%	1747
2021 Q3	$342K	Sell	13,600 -4,500	-25%	-$122K	﹤0.01%	1460
2021 Q2	$531K	Buy	+18,100	New	+$459K	0.01%	1161

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Steve Schonfeld's IPSC Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Century Therapeutics (IPSC) in Q2 2026: 21,532 shares worth $52.8K. The stake represents ﹤0.01% of the portfolio and ranks #2377 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in IPSC as recently as Q1 2024.

Steve Schonfeld first reported a position in IPSC in Q2 2021 and has held it in 5 quarters since. The position peaked at $531K in Q2 2021. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Steve Schonfeld held 21,532 shares of Century Therapeutics worth $52.8K as of Q2 2026.
Century Therapeutics was a new Steve Schonfeld position in Q2 2026.
Century Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2377 holding.
Steve Schonfeld first reported a position in Century Therapeutics in Q2 2021 and has held it in 5 quarters since.
Steve Schonfeld's Century Therapeutics position peaked at $531K in Q2 2021.
98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.